Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of mucosal healing in inflammatory bowel disease: review.
Dulai PS, Levesque BG, Feagan BG, D'Haens G, Sandborn WJ. Dulai PS, et al. Gastrointest Endosc. 2015 Aug;82(2):246-55. doi: 10.1016/j.gie.2015.03.1974. Epub 2015 May 21. Gastrointest Endosc. 2015. PMID: 26005012 Free PMC article. Review.
Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease.
Boland BS, Dulai PS, Chang M, Sandborn WJ, Levesque BG. Boland BS, et al. Among authors: dulai ps. Am J Gastroenterol. 2015 Nov;110(11):1631-2. doi: 10.1038/ajg.2015.326. Am J Gastroenterol. 2015. PMID: 26618431 Free PMC article. No abstract available.
Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
Jairath V, Zou G, Parker CE, Macdonald JK, Mosli MH, Khanna R, Shackelton LM, Vandervoort MK, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, Dulai PS, Glaire MA, Hoekman D, Koutsoumpas A, Minas E, Samaan MA, Travis S, D'Haens G, Levesque BG, Sandborn WJ, Feagan BG. Jairath V, et al. Among authors: dulai ps. J Crohns Colitis. 2016 May;10(5):607-18. doi: 10.1093/ecco-jcc/jjw004. Epub 2016 Jan 7. J Crohns Colitis. 2016. PMID: 26746169 Free PMC article. Review.
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.
Dulai PS, Singh S, Jiang X, Peerani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland BS, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF. Dulai PS, et al. Am J Gastroenterol. 2016 Aug;111(8):1147-55. doi: 10.1038/ajg.2016.236. Epub 2016 Jun 14. Am J Gastroenterol. 2016. PMID: 27296941
223 results